| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/14/2005 | EP1572995A2 Novel proteins and nucleic acids encoding same |
| 09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |
| 09/14/2005 | EP1572874A2 Antibodies that immunospecifically bind to trail receptors |
| 09/14/2005 | EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/14/2005 | EP1572719A2 Partial peptide mimetics and methods |
| 09/14/2005 | EP1572679A2 Crfr1 selective ligands |
| 09/14/2005 | EP1572669A2 2,5-diketopiperazines for the treatment of obesity |
| 09/14/2005 | EP1572214A1 Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction |
| 09/14/2005 | EP1572188A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders |
| 09/14/2005 | EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction |
| 09/14/2005 | EP1572172A1 Alpha2delta ligands for different pharmaceutical uses |
| 09/14/2005 | EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 09/14/2005 | EP1572074A2 Stabilized synthetic immunogen delivery system |
| 09/14/2005 | EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain |
| 09/14/2005 | EP1051179B1 Anti-estrogen plus progestin containing oral contraceptives |
| 09/14/2005 | CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 09/14/2005 | CN1668621A Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 09/14/2005 | CN1668309A Trimegestone and estrogens for treating post menopausal disorders |
| 09/14/2005 | CN1668305A Microbicidal pyrimidine or triazine for preventing sexual HIV transmission |
| 09/14/2005 | CN1668303A Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 09/14/2005 | CN1668285A Lasofoxifene tablet and its coating |
| 09/14/2005 | CN1666771A Chinese medicinal composition for treating chronic pelvic inflammatory disease |
| 09/14/2005 | CN1666756A Pain-relieving navel-applied paste |
| 09/14/2005 | CN1666744A Dry cow mamma perfusion agent for preventing and curing cow mastitis and preparation method thereof |
| 09/14/2005 | CN1666737A Application of citric acid solution in preparation of antiphlogistic drug |
| 09/14/2005 | CN1218731C Chinese medicine for treating dermatopathy and gynecopathy disease and its preparing process |
| 09/14/2005 | CN1218711C Pure Chinese medicine preparation for treating erection dysfunction |
| 09/14/2005 | CN1218703C Chitose antibacterial film of uterine neck |
| 09/14/2005 | CN1218694C Method for treating endometriosis or infertility, or improving fertility |
| 09/14/2005 | CN1218686C Process for preparing birth controller in pessary or uterus |
| 09/14/2005 | CN1218665C Defattedfrog spawn powder food for women |
| 09/13/2005 | US6943253 6-phenylpyrrolopyrimidinedione derivatives |
| 09/13/2005 | US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders. |
| 09/13/2005 | US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 09/13/2005 | US6943171 For therapy of urological, vascular or pulmonary disorders |
| 09/13/2005 | US6943163 7-Alkyl and cycloalkyl-substituted imidazotriazinones |
| 09/13/2005 | US6943160 Morpholine derivatives as antagonists of orexin receptors |
| 09/13/2005 | CA2292927C New imidazolin compounds, the process for preparing them and the pharmaceutical compositions that contain them |
| 09/09/2005 | WO2005082887A1 Pyrimidine derivative |
| 09/09/2005 | WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/09/2005 | CA2557541A1 Pyrimidine derivatives |
| 09/09/2005 | CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2) |
| 09/09/2005 | CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1) |
| 09/08/2005 | US20050197392 O-desmethylvenlafaxine and methods of preparing and using the same |
| 09/08/2005 | US20050197343 N-[(4-phenyl-1-piperazinyl)alkyl]-substituted heteroarene carboxamide or 2-ferrocenyl compounds; psychiatric diseases: schizophrenia , unipolar depression, disturbances of consciousness, antidepressant; neurodegenerative diseases: Parkinson's disease, attention deficit hyperactivity syndrome; drug abuse |
| 09/08/2005 | US20050197314 Synergistic combination of immunostimulatory CpG oligonucleotides and the immunopotentiating cytokine Flt3 ligand; immunotherapy of tumors, viral infections; cancer vaccines |
| 09/08/2005 | US20050197300 Microdose therapy |
| 09/08/2005 | US20050196470 Method and composition for enhancing sexual desire |
| 09/07/2005 | EP1571155A1 Peptides and medicinal compositions containing the same |
| 09/07/2005 | EP1570854A1 Drug containing angiotensin convertase |
| 09/07/2005 | EP1570848A1 Treating postmenopausal women using ultra-low doses of estrogen |
| 09/07/2005 | EP1569655A1 Use of selective progesterone receptor modulators for the treatment of androgen deficiency |
| 09/07/2005 | EP1569640A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 09/07/2005 | EP1569635A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 09/07/2005 | EP1501834B1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 09/07/2005 | EP1495023B1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 09/07/2005 | EP1401839B1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta [a] naphthalene |
| 09/07/2005 | EP1370279B1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 09/07/2005 | EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists |
| 09/07/2005 | EP1200107B1 Composition having steroidal estrogen effect without increasing the risk of breast cancer |
| 09/07/2005 | EP1089679B1 A device and method for the treatment of erectile dysfunction |
| 09/07/2005 | CN1665815A Novel tetracyclo-aryl-carbonyl indoles used as therapeutical agents with 5-hydroxy-tryptamine receptor affinity, their preparation process and pharmaceutical compounds containing same |
| 09/07/2005 | CN1665811A Carbamate-substituted pyrazolopyridines |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1665516A Infertility treatment with exemestane |
| 09/07/2005 | CN1665510A Cyclothiocarbamative derivatives as PR modulators and use thereof for treatment of skin disorders |
| 09/07/2005 | CN1665508A Use of pyrazolo[4, 3-d]pyrimidines |
| 09/07/2005 | CN1665503A Utilization of heteroarene carboxamide as dopamine-D3 ligands for the treatment of cns diseases |
| 09/07/2005 | CN1665485A Compositions and methods for amelioration of human female sexual dysfunction |
| 09/07/2005 | CN1665484A Warming and nonirritating lubricant compositions and method of comparing irritation |
| 09/07/2005 | CN1663596A Suppository for treating chronic cervicitis |
| 09/07/2005 | CN1663593A Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation and medical usage |
| 09/07/2005 | CN1663573A A stable and safe microecological formulation, its preparation and usage |
| 09/07/2005 | CN1217938C Bis-arylsulfones |
| 09/07/2005 | CN1217918C Aminocyclohexyl ether compounds and uses thereof |
| 09/07/2005 | CN1217686C Preparation method of dairy cattle mammitis antinflammation powder |
| 09/07/2005 | CN1217680C Repellent mixture for treating uterus tumor and oophoritic cyst |
| 09/07/2005 | CN1217675C Medicine for treating menopausal syndrome and preparation process thereof |
| 09/07/2005 | CN1217670C Lubricating fluid for sexual intercourse |
| 09/07/2005 | CN1217663C Use of ligustrazine in preparing medicine for treating penis erection dysfunction |
| 09/07/2005 | CN1217655C Fibrauretine slow releasing preparation |
| 09/06/2005 | US6939992 Polymorphic forms of sertraline hydrochloride |
| 09/06/2005 | US6939990 Derivatives of dicarboxylic acid having pharmaceutical properties |
| 09/06/2005 | US6939989 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/06/2005 | US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 09/06/2005 | US6939880 Compounds with growth hormone releasing properties |
| 09/06/2005 | US6939568 Hydrated dressing containing metal microbiocide |
| 09/01/2005 | WO2002083873A3 Enzymes |
| 09/01/2005 | US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 09/01/2005 | US20050192318 5-[4-Methylsulfonyloxy-2-(S)-(3,4-dichlorophenyl)butyl]-10-cyano-3-(R)-methyl-6-oxo-3,4,5,6-tetrahydro-2H-benzo[b][1,5]oxazocine as antidepressant |
| 09/01/2005 | US20050192304 Rho-kinase inhibitors |
| 09/01/2005 | US20050192266 Including vanadocene dihalides, bis(methylcyclopentadienyl), vanadocene diazide, vanadocene dicyanide, vanadocene dioxycyanate, vanadocene dithiocyanate, vanadocene diselenocyanate, vanadocene ditriflate, vanadocene monochloro oxycyanate, vanadocene monochloro acetonitrilo tetrachloro ferrate |
| 09/01/2005 | US20050192260 Pharmaceutical composition |
| 09/01/2005 | US20050192235 Compositions and methods for treating or preventing diseases of body passageways |
| 09/01/2005 | US20050192208 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators ; potassium channel moderators; prevent fibrillation |
| 09/01/2005 | US20050191641 Nucleotide sequences coding hydrolase for use as tool in identifying modulators for prevention and treatment of digestion, coagulation, diabetic, cell proliferative, urogenital, eating and nervous system gynecological disorders |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 08/31/2005 | EP1568699A1 1,3-dihydroimidazole fused-ring compound |
| 08/31/2005 | EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen |